Core Viewpoint - The article highlights the launch of three chromatography instruments by Haikejing Medical Technology, a subsidiary of Haomuxing, which enhances domestic capabilities in high-end analytical instruments and provides advanced detection solutions for various industries including clinical diagnostics, environmental monitoring, and food safety [2][4]. Group 1: Product Launch - Haikejing Medical Technology has officially launched three core products: the two-dimensional liquid chromatography instrument, H-1000 liquid chromatography instrument, and H-5000 ion chromatography instrument, marking a significant advancement in China's self-developed high-end analytical instruments [2][3]. - The H-1000 liquid chromatography instrument features an advanced fluid control system and intelligent operation platform, offering high sensitivity, high repeatability, and rapid analysis capabilities, suitable for environmental monitoring and food testing [3]. - The two-dimensional liquid chromatography instrument significantly improves separation efficiency and analytical capability for complex samples, particularly beneficial for clinical in vitro diagnostics such as drug concentration testing [4]. - The H-5000 ion chromatography instrument is characterized by high precision and low detection limits, effectively quantifying anions and cations in environmental water quality, food additives, and pharmaceuticals, aiding in industry compliance monitoring [6]. Group 2: Technological Innovation - The three chromatography instruments have achieved domestic substitution of key components, enhancing industry autonomy. The two-dimensional liquid chromatography instrument employs a three-pump series flow path design and intelligent gradient control technology, significantly improving analytical efficiency [8]. - The ion chromatography instrument utilizes a high-performance, low-pulse PEEK dual-piston constant flow pump, along with a high-precision stepper motor-driven precision ball screw system, enhancing performance, reliability, stability, and durability [8]. Group 3: Future Development and Collaboration - The successful development of these chromatography instruments is a key achievement in the company's strategy of "technology as the core, application as the foundation." The company plans to increase R&D investment and expand applications in life sciences, environmental monitoring, and new materials [9]. - Haikejing Medical Technology has established cooperation intentions with several renowned universities and third-party testing institutions, with some products entering the stage of large-scale production [9].

Core Viewpoint - The company has achieved a localization rate of over 95% for key components, with the autonomy rate for controllers reaching over 99%, indicating a strong focus on domestic production and reduced reliance on imports [1] Group 1 - The localization rate for key components is now over 95% [1] - The autonomy rate for controllers has reached over 99% [1] - Only a small number of components will still be imported [1]